Andreas Krebs
Directeur/Membre du Conseil chez MIND MEDICINE (MINDMED) INC.
Fortune : 99 590 $ au 30/04/2024
Provenance du réseau au premier degré de Andreas Krebs
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
| Public Company | Pharmaceuticals: Major | 13 | |
Merz Pharma GmbH & Co. KGaA
 Merz Pharma GmbH & Co. KGaA Miscellaneous Commercial ServicesCommercial Services Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning. The units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Ober Scharrer Gruppe GmbH
 Ober Scharrer Gruppe GmbH Medical/Nursing ServicesHealth Services Ober Scharrer Gruppe GmbH provides eye care services. The company is based in Fuerth, Germany. and has subsidiaries in Germany. The CEOs are Markus Hamm, Sibylle Stauch-Eckmann. The German company was founded in 1982 by Manuel Ober, Armin Scharrer.
4
| Holding Company | Medical/Nursing Services | 4 |
Paul Ehrlich-Foundation
2
| Non-Profit Organization | 2 | |
City of Frankfurt am Main (Germany)
1
| Government | Municipality | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Andreas Krebs via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Notre Dame | College/University | Masters Business Admin Undergraduate Degree | |
Ulthera, Inc.
 Ulthera, Inc. Medical SpecialtiesHealth Technology Ulthera, Inc. provides ultrasound therapy under the Ultherapy brand. It focuses on ultrasound imaging to to deliver its collagen-boosting treatment. The company was founded by Peter G. Barthe, Inder Raj S. Makin, Brain D. Oconner, Lana Slayton, and Michael H. Slayto n in April 2004 and is headquartered in Raleigh, NC. | Medical Specialties | Director/Board Member Director/Board Member | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| STADA ARZNEIMITTEL | Pharmaceuticals: Other | Director/Board Member | |
| REALTECH AG | Miscellaneous Commercial Services | Chairman | |
| University of Freiburg | College/University | Graduate Degree | |
Ratiopharm GmbH
 Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
| Technische Universität München | College/University | Doctorate Degree Doctorate Degree | |
| University of Augsburg | College/University | Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree | |
| University of Mannheim | College/University | Doctorate Degree Undergraduate Degree | |
Eichbaum-Brauereien AG /Keilbach/
 Eichbaum-Brauereien AG /Keilbach/ Financial ConglomeratesFinance Eichbaum-Brauereien AG /Keilbach/ is led by Jochen Keilbach. The private company is based in Mannheim, Germany. | Financial Conglomerates | Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Graduate Degree | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
| MOUNT LOGAN CAPITAL INC. | Investment Managers | Director/Board Member Director of Finance/CFO | |
| Canadian Olympic Foundation | Investment Managers | Chairman Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Founder Chief Executive Officer | |
Rottendorf Pharma GmbH
 Rottendorf Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of Rottendorf-Stiftung, Rottendorf Pharma GmbH is a German company that engages in manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the pharmaceutical industry. The company is based in Ennigerloh, Germany. The company was founded in 1928 by Andreas J. Rottendorf. The CEO is Stephan Fleck. | Pharmaceuticals: Major | Director/Board Member | |
SRH Kliniken GmbH
 SRH Kliniken GmbH Hospital/Nursing ManagementHealth Services Part of SRH Holding (SdbR), SRH Kliniken GmbH is a healthcare company that operates multiple clinics across Germany, including locations in Gera, Karlsbad-Langensteinbach, Bad Wimpfen, Neresheim, Oberndorf a.N., Bad Kösen, and others. The company is based in Heidelberg, Germany. The company provides medical services and treatments to patients in these regions. The CEO of the company is Werner Stalla. | Hospital/Nursing Management | Chairman | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
 RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB Miscellaneous Commercial ServicesCommercial Services RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact Director of Finance/CFO | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member Director/Board Member | |
Wilex, Inc.
 Wilex, Inc. Medical/Nursing ServicesHealth Services Part of Nuclea Biotechnologies, Inc., Wilex, Inc. develops medical diagnostic tests. The company is based in Cambridge, MA. The CEOs of the company are Thomas Borcholte, Olaf G. Wilhelm. Wilex was acquired by Nuclea Biotechnologies, Inc. from Heidelberg Pharma AG on September 06, 2013. | Medical/Nursing Services | Chief Executive Officer Director of Finance/CFO Chief Executive Officer | |
ASSIMA Verbundgesellschaft mbH & Co. KG
 ASSIMA Verbundgesellschaft mbH & Co. KG Internet RetailRetail Trade ASSIMA Verbundgesellschaft mbH & Co. KG is a German company that specializes in mail order and internet retailing of textiles, clothing, footwear, and leather products. The private company is based in Neuss, Germany. The company was founded in 2002, and the CEO is Siegfried Despineux. | Internet Retail | Director/Board Member | |
| MELODIOL GLOBAL HEALTH LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| MAS Consult AG | Director/Board Member | ||
Bormioli Pharma SpA
 Bormioli Pharma SpA Miscellaneous ManufacturingProducer Manufacturing Bormioli Pharma SpA designs and manufactures pharmaceutical packaging solutions. It offers packaging for dual-chamber system, oral, parenteral, ophthalmic and nasal drugs. The company was founded in 2017 and is headquartered in Parma, Italy. | Miscellaneous Manufacturing | Director/Board Member | |
HealthMode, Inc.
 HealthMode, Inc. Packaged SoftwareTechnology Services Part of Mind Medicine (MindMed), Inc., HealthMode, Inc. drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. The company is based in San Francisco, CA. HealthMode's measurement techniques improve understanding of phenotype, streamline and provide assurance for screening and eligibility, provide early detection and mitigation of adverse events, and serve as sensitive, specific, objective, and low participant burden efficacy endpoints. These measurements allow for meaningful integration of clinical trial data with real-world evidence, and provide the basis for movement toward patient-specific measures. Better measurement tools and the platforms to support them help HealthMode's partners make data-informed decisions, reduce uncertainty around enrollment and outcomes, de-risk development, and increase the speed at which novel therapeutics reach patients in need. The company was founded by Bradford Cross, Daniel R. Karlin. HealthMode was acquired by Mind Medicine (MindMed), Inc. on February 26, 2021 for $41.54 million. | Packaged Software | Founder Chief Executive Officer | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Allemagne | 34 |
| Etats-Unis | 12 |
| Royaume-Uni | 3 |
| Suisse | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 18 |
| Consumer Services | 10 |
| Commercial Services | 10 |
| Finance | 7 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 211 |
| Corporate Officer/Principal | 107 |
| Chief Executive Officer | 82 |
| Chairman | 67 |
| Independent Dir/Board Member | 50 |
Relations les plus connectées
| Insiders | |
|---|---|
| Perry Dellelce | 40 |
| Christof Hettich | 40 |
| Bruce Linton | 40 |
| David Ebsworth | 26 |
| Carol Vallone | 24 |
| Stefan Oschmann | 23 |
| Geneviéve B. Berger | 23 |
| Wolfgang Plischke | 21 |
| Dave Guebert | 21 |
| David Gryska | 20 |
| Mathias Hothum | 19 |
| Suzanne Bruhn | 18 |
| Peter Llewellyn-Davies | 14 |
| Alexandra Goll | 14 |
| Brigid Makes | 14 |
- Bourse
- Insiders
- Andreas Krebs
- Connexions Sociétés
